HCA Healthcare (HCA) Earnings Dates, Call Summary & Reports

The earnings call demonstrated strong revenue and earnings growth despite external challenges such as hurricanes. Operational resilience and successful recovery efforts were highlighted, though certain areas like professional fees and outpatient surgery volumes posed challenges. Overall, the positives, such as strong cash flow and shareholder returns, outweighed the negatives.

Company Guidance

During the HCA Healthcare Fourth Quarter 2024 Earnings Call, the guidance provided for 2025 highlighted several key financial metrics. The company projects revenues to range between $72.8 billion and $75.8 billion, with net income attributable to HCA Healthcare expected to be between $5.85 billion and $6.29 billion. Adjusted EBITDA is anticipated to range from $14.3 billion to $15.1 billion, and diluted earnings per share are forecasted to be between $24.05 and $25.85. HCA plans to allocate approximately $5 billion to $5.2 billion in capital spending. The guidance assumes equivalent admissions growth of 3% to 4%, with net revenue per equivalent admission increasing by 2% to 3%. The company also addressed the impact of hurricanes, indicating a neutral effect on 2025 EBITDA, and provided insights on Medicaid supplemental payment programs, projecting a potential $250 million headwind. Additionally, HCA announced a new $10 billion share repurchase program and an increase in its quarterly dividend from $0.66 to $0.72 per share.

Strong Earnings and Revenue Growth

Diluted earnings per share, as adjusted, increased 5.4% in the fourth quarter with revenue growth of approximately 6%. Full year revenue grew by 8.7%. Adjusted EBITDA increased 9% over the prior year.

Operational Resilience and Recovery

The company successfully remediated facilities impacted by hurricanes and resumed normal operations. Despite the hurricanes, adjusted EBITDA margin and cash flow from operations remained strong.

Positive Volume Trends

Inpatient admissions and equivalent admissions grew by 3%, with emergency room visits increasing by 2.4% and inpatient surgeries up by 2.8%.

Cash Flow and Shareholder Returns

Cash flow from operations was $10.5 billion for the year, an 11% increase. The company repurchased $6 billion of outstanding shares and paid $690 million in dividends for the year.

---

HCA Healthcare (HCA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

HCA Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Jul 25, 2018	2018 (Q2)	- / 2.29	1.75	30.86% (+0.54)	―	―
Oct 30, 2018	2018 (Q3)	- / 2.16	1.21	78.51% (+0.95)	―	―
Jan 29, 2019	2018 (Q4)	- / 2.99	2.13	40.38% (+0.86)	―	―
Apr 30, 2019	2019 (Q1)	- / 2.97	2.33	27.47% (+0.64)	―	―
Jul 30, 2019	2019 (Q2)	- / 2.21	2.29	-3.49% (-0.08)	―	―
Oct 29, 2019	2019 (Q3)	- / 2.23	2.16	3.24% (+0.07)	―	―
Jan 28, 2020	2019 (Q4)	- / 3.09	2.99	3.34% (+0.10)	―	―
Apr 21, 2020	2020 (Q1)	- / 2.33	2.97	-21.55% (-0.64)	―	―
Jul 22, 2020	2020 (Q2)	- / 3.23	2.21	46.15% (+1.02)	―	―
Oct 26, 2020	2020 (Q3)	- / 1.92	2.23	-13.90% (-0.31)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

---

HCA Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jan 24, 2025	$325.36	$313.07	-3.78%
Oct 25, 2024	$398.06	$362.78	-8.86%
Jul 23, 2024	$324.15	$338.88	+4.54%
Apr 26, 2024	$312.32	$304.94	-2.36%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

---